Rene Letourneau
According to its recent Community Benefits Report, the Iowa Hospital Association's 118 community hospitals provided more than $1.3 billion in community benefits in 2010.
A Houston-area nursing home employee was arrested last week on charges of conspiracy, healthcare fraud and violations of the anti-kickback statute for unlawfully billing federal healthcare programs for ambulance transport, announced U.S. Attorney José Angel Moreno and Texas Attorney General Greg Abbott.
Medicare average prescription drug premiums will not increase in 2012 and the cost of the average Medicare prescription drug plan premium will remain largely unchanged, announced the Department of Health and Human Services (HHS) on Thursday.
Lack of breastfeeding in the U.S. costs $2.2 billion annually in medical expenses for diseases that could have been prevented, says a new report from the Centers for Disease Control and Prevention.
A senate committee released a report Wednesday that shows access to child-only health insurance plans has declined significantly since passage of the Affordable Care Act.
Grants totaling $71.3 million will be awarded to expand nursing education, training and diversity, announced Department of Health and Human Services Secretary Kathleen Sebelius on Friday.
Spiraling healthcare expenditures paralleled by increasing costs and premium rates of medical care are creating a real and urgent need for reform in the medical technology sector worldwide, according to a new analysis from Frost & Sullivan.
In its annual Diagnostic Imaging Watch, released in June, the healthcare supply contracting firm Novation reported that, after a three-year decline in sales of capital diagnostic imaging equipment, hospitals and imaging centers appear to be resuming the acquisition process.
Assuming there is no new legislation to the contrary in the next few months, Accountable Care Organizations will begin operating nationwide in January 2012.
With patent expirations looming for some of the world's top-selling brand name drugs, the outlook for the global pharmaceutical industry is negative, said Moody's in its annual Industry Outlook report, released in June.